Dock3 Protein Dedicator Of Cytokinesis 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DOCK3 is a member of the DOCK family of atypical guanine nucleotide exchange factors (GEFs). It is primarily expressed in neurons and activates Rac1 and Cdc42 GTPases to regulate actin cytoskeleton dynamics, neurite outgrowth, and synaptic function [1].
DOCK3 is a large protein with multiple functional domains:
- Molecular Weight: ~220 kDa
- Domain Organization: Contains DOCK homology region (DHR) domains
¶ Functional Domains
- DHR-1 Domain: Binds phosphoinositides and contributes to membrane localization
- DHR-2 Domain: The catalytic GEF domain that activates Rac1/Cdc42
- SH3 Domains: Mediate protein-protein interactions
DOCK3 is a Rac1/Cdc42-specific GEF:
- Rac1 Activation: DOCK3 catalyzes GDP-GTP exchange on Rac1 [2]
- Cdc42 Activation: Can also activate Cdc42 to a lesser extent
- Cellular Localization: Enriched in neuronal processes and synapses
DOCK3 plays several important roles in neurons:
- Neurite Outgrowth: Promotes axonal and dendritic extension
- Synaptic Formation: Contributes to synapse development and plasticity
- Axonal Guidance: Helps guide axonal projections
- Actin Dynamics: Orchestrates actin cytoskeleton remodeling
DOCK3 interacts with several neuronal signaling pathways:
- PI3K/Akt: DOCK3 can activate PI3K signaling
- Wnt Signaling: Modulates β-catenin dependent transcription
- Growth Factor Signaling: Works with neurotrophin pathways
DOCK3 is implicated in ALS pathogenesis:
- Motor Neuron Expression: Highly expressed in vulnerable motor neurons
- Cytoskeletal Dysfunction: Altered Rac1 signaling affects neuronal morphology
- Axonal Transport: Cytoskeletal abnormalities impair axonal transport [3]
- Dopaminergic Neurons: May be important for survival of dopaminergic neurons
- Synaptic Function: Contributes to synaptic maintenance
- Axonal Integrity: Maintains axonal projections
- Axonal Transport Defects: Common in many neurodegenerative conditions
- Synaptic Loss: Contributes to synaptic degeneration
- Brugnera et al., DOCK family (2002)
- Miyamoto et al., DOCK3 function (2006)
- Bilsland et al., GEFs in neurodegeneration (2006)
The study of Dock3 Protein Dedicator Of Cytokinesis 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Bravi et al., DOCK3 in Wiskott-Aldrich syndrome and neurodegeneration (Human Molecular Genetics, 2015)
- Chen et al., DOCK3 in neuronal morphogenesis and axon guidance (Journal of Neuroscience, 2014)
- Nakamura et al., DOCK3 mutations in Charcot-Marie-Tooth disease (Neurology, 2016)
- Zhang et al., DOCK3 in Alzheimer's disease pathogenesis (Journal of Alzheimer's Disease, 2019)
- Huang et al., DOCK3 and neuronal signaling (Cellular and Molecular Neurobiology, 2018)
- Miyamoto et al., DOCK3 in synaptic plasticity and memory (Learning & Memory, 2017)
- Qian et al., DOCK3 in axonal regeneration after injury (Experimental Neurology, 2019)
- Watabe et al., DOCK family in neuronal development (Developmental Neurobiology, 2016)